Factors influencing shared decision-making and decision regret in parents of children undergoing myopia control within one year

影响近视矫正儿童父母一年内共同决策和决策后悔的因素

阅读:1

Abstract

BACKGROUND: Childhood myopia is highly prevalent in East Asia, where treatment decisions are typically made by parents. Although effective interventions are available, little is known about how parental knowledge and involvement influence decision quality. This study examined the relationships among parental knowledge, shared decision-making (SDM), and decision regret in parents of children with myopia, and assessed how treatment type and follow-up behaviors affect decision-making experiences. METHODS: A cross-sectional survey was conducted with 314 parents of children newly diagnosed with myopia. Data were collected using an online questionnaire that captured demographic and clinical characteristics, treatments received by the children, parents' knowledge of myopia control, SDM, and decision regret. Multiple regression analysis was performed to identify the predictors of decision regret. RESULTS: Shorter follow-up intervals (≤ 6 months), higher parental knowledge, and the use of orthokeratology were significantly associated with lower decision regret, whereas atropine therapy was associated with higher regret. However, when SDM was included in the final model, treatment type was no longer a significant predictor, and SDM emerged as the strongest negative predictor of regret (unstandardized regression coefficient [B] = -0.410, 95% confidence interval [CI] [-0.507, - 0.314], p < .001). This attenuation suggests that the observed relationship between treatment type and decision regret may be partly explained by differences in SDM, potentially reflecting more extensive consultation and engagement in certain modalities such as orthokeratology. The final model explained 27.4% of the variance in decision regret. CONCLUSIONS: SDM plays a critical role in reducing parents' decision regret, regardless of the treatment modality. Enhancing communication about treatment options, particularly atropine therapy and axial length monitoring, may support more informed and satisfactory decision-making. The development of longitudinal studies and SDM tools tailored for parents with lower literacy is recommended to strengthen treatment adherence and improve clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。